From molecule to market—faster.
Partner with a growing end-to-end contract development and manufacturing organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies.
Curious about how our CDMO services can help your organization?
We’d love to hear from you.
The potential of radioligand therapy is undeniable, but bottlenecks in clinical development, manufacturing, and supply chain logistics slow progress.
We are here to change that.
A CDMO collaborator, not competitor
We do not compete with our clients—we partner with them to ensure life-saving radioligand therapies reach patients efficiently and cost-effectively.
Go from breakthrough to reality
Robust manufacturing infrastructure
We focus exclusively on manufacturing and supply chain—not isotope production—so you can bring your radiopharmaceuticals to patients faster.
- Clinical & commercial manufacturing
- Regulatory & compliance expertise
- White-label packaging & distribution
A CDMO that adapts to you
Our facilities are designed from the ground up to support any formula, any process, any isotope without the limitations of legacy infrastructure.
- Customizable manufacturing
- Faster R&D to production transition
- Reliable, rapid delivery
Not every CDMO has the scientific expertise and network needed to develop, manufacture, and deliver your radiotherapeutics.
We do.
Nucleus RadioPharma thrives from a fresh start, free from legacy constraints. This, combined with an experienced team and open communication, fuels the innovative thinking needed to scale and launch groundbreaking radiopharmaceuticals.”
– Conrad Wüller
ARTBIO